Partnerships are central to Avectas. With a growing list of partnerships with academic institutions, biotechnology and pharmaceutical companies, our core objective is to enable innovative therapies, especially in the area of gene editing, cell therapy and immune therapy, with a particular focus on treating patients.

We are actively seeking licensing and development partnership opportunities with companies dedicated to bringing safe and effective advanced therapeutics to patients. Contact us today.


Avectas attends key scientific and commercial meetings throughout the year. See our schedule of upcoming meetings and events here. Let us know if you are attending the same meeting.